Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 贝达药业股份有限公司章程对照表 | 2025-12-15 | Chinese | |
| 独立董事提名人声明与承诺（黄欣琪） | 2025-12-15 | Chinese | |
| 独立董事提名人声明与承诺（肖佳佳） | 2025-12-15 | Chinese | |
| 关于参加独立董事培训并取得独立董事资格证书的承诺函（JIANWEI XUAN） | 2025-12-15 | Chinese | |
| 关于使用部分闲置募集资金暂时补充流动资金的公告 | 2025-12-15 | Chinese | |
| 关于2026年度日常关联交易预计的公告 | 2025-12-15 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37811532 | 贝达药业股份有限公司章程对照表 | 2025-12-15 | Chinese | ||
| 37811530 | 独立董事提名人声明与承诺（黄欣琪） | 2025-12-15 | Chinese | ||
| 37811525 | 独立董事提名人声明与承诺（肖佳佳） | 2025-12-15 | Chinese | ||
| 37811514 | 关于参加独立董事培训并取得独立董事资格证书的承诺函（JIANWEI XUAN） | 2025-12-15 | Chinese | ||
| 37811510 | 关于使用部分闲置募集资金暂时补充流动资金的公告 | 2025-12-15 | Chinese | ||
| 37811499 | 关于2026年度日常关联交易预计的公告 | 2025-12-15 | Chinese | ||
| 37811488 | 贝达药业股份有限公司股东会议事规则（草案）（2025年12月） | 2025-12-15 | Chinese | ||
| 37811487 | 贝达药业股份有限公司独立董事工作制度（草案）（2025年12月） | 2025-12-15 | Chinese | ||
| 37811484 | 贝达药业股份有限公司独立董事工作制度（2025年12月） | 2025-12-15 | Chinese | ||
| 37811482 | 贝达药业股份有限公司对外投资管理制度（草案）（2025年12月） | 2025-12-15 | Chinese | ||
| 37811469 | 关于修订H股发行并上市后适用的《公司章程（草案）》及相关内部治理制度（草案）的公告 | 2025-12-15 | Chinese | ||
| 37811465 | 第四届监事会第二十五次会议决议公告 | 2025-12-15 | Chinese | ||
| 37811454 | 贝达药业股份有限公司章程（2025年12月） | 2025-12-15 | Chinese | ||
| 37811451 | 贝达药业股份有限公司章程（草案）（2025年12月） | 2025-12-15 | Chinese | ||
| 37811448 | 独立董事候选人声明与承诺（肖佳佳） | 2025-12-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.